News » MHRA alert » Recall: Suprefact 1mg/ml
April 25th 2024
Neon Healthcare Ltd is recalling one batch of Suprefact 1 mg/ml solution for injection (buserelin acetate), branded Cheplapharm.
The affected batch is:
| Batch Number | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 3F022A | 12/2024 | 2 multi-dose vials of 5.5ml | 11 April 2024 |
The recall is a precautionary measure as the affected batch is packaged for the Canadian market by Cheplapharm, instead of the correct UK packaging by Neon Healthcare Ltd for Buserelin 1 mg/ml solution for injection.
Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier using your supplier’s approved process. No action is required by patients.
For medical information or stock control enquiries please contact: Neon Healthcare Ltd via Medinfo@neonhealthcare.com or +44 (0) 1992 926 330
